Stockreport

H.C. Wainwright Lifts PT on BioCryst Pharmaceuticals (BCRX) to $32 From $30 [Yahoo! Finance]

BioCryst Pharmaceuticals, Inc.  (BCRX) 
Last biocryst pharmaceuticals, inc. earnings: 3/5 07:05 am Check Earnings Report
US:NASDAQ Investor Relations: biocryst.gcs-web.com/investor-relations
PDF Wainwright lifted the price target on BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) to $32 from $30 on December 15, and reaffirmed a Buy rating on the stock. The firm told [Read more]